| |
| |
|
| Insider
Information: |
Dilly Stephen George |
| Relationship: |
CEO and President, Dir... |
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
912,611 |
|
|
Indirect Shares
|
131,700 |
|
|
| Direct
Value |
$13,008,239 |
|
|
|
Indirect Value
|
$4,542,333 |
|
|
| Total
Shares |
1,044,311 |
|
|
| Total
Value |
$17,550,572 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
2
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-2.0
|
| Percentage
Gain/Loss : |
 93.5%
|
 -115.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aimmune Therapeutics, Inc. |
AIMT |
President and CEO, Dir... |
2018-06-11 |
315,308 |
2018-06-11 |
131,700 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Director |
2020-05-18 |
15,000 |
2018-06-11 |
0 |
Premium* |
|
|
Codexis Inc |
CDXS |
|
2024-01-01 |
582,303 |
2020-06-16 |
0 |
Premium* |
|
|
Sierra Oncology Inc |
SRRA |
CEO and President, Dir... |
2022-07-01 |
0 |
2021-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEOOfficer |
• • – |
2015-08-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
765,308 |
|
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEOOfficer |
• • – |
2015-08-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
131,700 |
|
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-07-25 |
4 |
GA |
$0.00 |
$0 |
D/D |
14,447 |
779,755 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-07-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
14,447 |
14,447 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-07-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
28,894 |
51,403 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-08-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
28,894 |
14,447 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
14,447 |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
14,447 |
765,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-11-10 |
4 |
AS |
$25.00 |
$32,600 |
D/D |
(1,304) |
764,004 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2016-11-11 |
4 |
AS |
$25.00 |
$1,217,990 |
D/D |
(48,696) |
715,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2017-05-10 |
4 |
AS |
$20.15 |
$12,090 |
D/D |
(600) |
714,708 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-06-23 |
4 |
AS |
$20.21 |
$998,591 |
D/D |
(49,400) |
665,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-07-26 |
4 |
AS |
$21.46 |
$1,073,110 |
D/D |
(50,000) |
615,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-08-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
102,806 |
20,656 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-08-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
102,806 |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-09-25 |
4 |
AS |
$25.01 |
$2,500,790 |
D/D |
(100,000) |
515,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-10-04 |
4 |
AS |
$26.21 |
$2,101,353 |
D/D |
(80,110) |
435,198 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-10-05 |
4 |
AS |
$26.24 |
$385,495 |
D/D |
(14,689) |
420,509 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-10-06 |
4 |
AS |
$26.31 |
$106,468 |
D/D |
(4,047) |
416,462 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2017-10-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,876 |
25,532 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2017-10-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,876 |
12,009 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
President and CEO |
• • – |
2017-10-16 |
4 |
AS |
$26.24 |
$30,279 |
D/D |
(1,154) |
415,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2017-10-23 |
4 |
AS |
$33.23 |
$3,354,538 |
D/D |
(100,000) |
315,308 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2018-06-01 |
4 |
OE |
$3.02 |
$184,943 |
D/D |
61,197 |
376,505 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
See Remarks |
• • – |
2018-06-01 |
4 |
AS |
$32.59 |
$1,995,993 |
D/D |
(61,197) |
315,308 |
0 |
- |
|
56 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
